Healthcare’s Digital Revolution: Part I
Just as smartphones are replacing books within the personal realm, electronic tablets are quickly taking the place of paper in doctors’ offices, and are doing so on a global scale.
feature2
“Rockstar of Science”, Eric Topol M.D. Talks The Creative Destruction of Medicine
Author of “The Creative Destruction of Medicine: How the Digital Revolution Will Create Better Healthcare”, Dr. Eric Topol sits down with OneMedRadio to discuss the ideas and inspiration behind the book.
The Future of Healthcare: Part II, The Waiting Room of Tomorrow
In Part II of our expert series on the future of healthcare and The Patient, OneMedSentinel sits down with Dr. Cynthia Haines to discuss the digitization of the waiting room.
OneMedForum NY 2012 Sponsor Aptiv Solutions Educates the Market on Adaptive Clinical Trials
Aptiv Solutions is a full-service international CRO with proven expertise in supporting global clinical trials for biopharmaceutical and medical device companies. Their trials span the development lifecycle from first-in-human through regulatory approval and beyond.
Compassionate Use of Pluristem’s PLX Cells Saves the Life of a Child after Bone Marrow Transplantation Failure
IM Injections of PLX Cells Causing a Dramatic Recovery of Blood Forming Cells.
Dr. James Tong of Tianyin Pharmaceuticals Discusses New Manufacturing Facility and Promising Future Milestones
Headquartered at Chengdu, China, TPI is a pharmaceutical company that specializes in modernized traditional Chinese medicines and branded generics.
July 12, 2012 OneMedForum New York
OneMedForum NY2012 To Feature Expert Panels, Investor Guides and Disruptive Technologies from Emerging Companies. The 3rd Annual Healthcare Investment Conference Will Be Held in New York City, July 12th, 2012
Neurometrix Focuses on Diabetes-Related Nerve Damage
President and CEO, Dr. Shai Gozani is interviewed by OneMedRadio where he discusses the Sensus Pain Therapy device.
This Week in Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
NanoViricides Announces Issuance of a Fundamental Patent in the USA
NanoViricides, Inc. (OTC BB: NNVC) announced that a fundamental patent, on which the nanoviricides® technology is based, is due to be issued in the USA on May 8, 2012. The issuance notification was received from the US Patents and Trademarks Office last week.